Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Sienna Biopharma Raises USD40 million in Series B Financing 12
Sienna Biopharma Raises Additional USD12 Million in Series A Financing 14
Sienna Biopharma Raises USD34 Million in Series A Financing 15
Sienna Biopharma Raises USD18.4 Million in Financing 16
Equity Offering 17
Sienna Biopharma Plans to Raise up to USD75 Million in Public Offering of Shares 17
Sienna Biopharma Raises USD74.7 Million in IPO 18
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 20
Acquisition 21
Sienna Biopharmaceuticals Acquires Creabilis 21
Sienna Biopharmaceuticals Inc – Key Competitors 22
Sienna Biopharmaceuticals Inc – Key Employees 23
Sienna Biopharmaceuticals Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 09, 2018: Sienna Biopharmaceuticals reports second quarter 2018 financial results 25
May 14, 2018: Sienna Biopharmaceuticals Reports First Quarter 2018 Financial Results 27
Mar 15, 2018: Sienna Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 28
Nov 09, 2017: Sienna Biopharmaceuticals Reports Third Quarter 2017 Financial Results 30
Sep 07, 2017: Sienna Biopharmaceuticals Reports Second Quarter 2017 Financial Results 31
Corporate Communications 32
Aug 02, 2018: Sienna Biopharmaceuticals Appoints Finance Veteran, James M. Hindman, to Board of Directors 32
Mar 22, 2018: Sienna Biopharmaceuticals Appoints Caroline Van Hove as Chief Commercial Officer 33
Mar 21, 2018: Sienna Biopharmaceuticals Appoints John W. Smither as Chief Financial Officer 34
Jun 14, 2017: Sienna Biopharmaceuticals Appoints Erle Mast, Former CFO and Co-Founder of Clovis Oncology, to Board of Directors 35
Mar 24, 2017: Richard Peterson Joins Sienna Biopharmaceuticals As Chief Financial Officer 36
Legal and Regulatory 37
May 07, 2018: Sebacia Announces Favorable Ruling by U.S. Court of Appeals for the Federal Circuit Regarding Patent Interference Proceedings with Sienna Biopharmaceuticals 37
Product News 38
03/12/2018: Sienna Biopharmaceuticals Announces First Patient Dosed in Proof-of-Concept Trial of Topical by Design JAK Inhibitor SNA-125 for Atopic Dermatitis 38
02/14/2018: Sienna Biopharmaceuticals Announces First Patient Dosed in First-in-Human Trial of Topical SNA-125 39
Clinical Trials 40
Oct 24, 2017: Sienna Biopharmaceuticals Announces First Patient Dosed in Phase 2b Trial of Topical SNA-120 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sienna Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sienna Biopharma Raises USD40 million in Series B Financing 12
Sienna Biopharma Raises Additional USD12 Million in Series A Financing 14
Sienna Biopharma Raises USD34 Million in Series A Financing 15
Sienna Biopharma Raises USD18.4 Million in Financing 16
Sienna Biopharma Plans to Raise up to USD75 Million in Public Offering of Shares 17
Sienna Biopharma Raises USD74.7 Million in IPO 18
Sienna Biopharma Raises USD0.6 Million in Private Placement of Shares 20
Sienna Biopharmaceuticals Acquires Creabilis 21
Sienna Biopharmaceuticals Inc, Key Competitors 22
Sienna Biopharmaceuticals Inc, Key Employees 23
Sienna Biopharmaceuticals Inc, Subsidiaries 24
List of Figures
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sienna Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sienna Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10